** Immunotherapy developer's shares ONCS.O up 7.3 pct at
$1.61 premarket
** Company gets $15 mln investment from Korea-based firm
Alpha Holdings 117670.KQ
** Says Alpha Holdings to purchase $15 mln worth of shares
from OncoSec at $1.50/shr urn:newsml:reuters.com:*:nPnc6Zg0Ba
** Says investment centered on clinical development of
company's lead immunotherapy product candidate TAVO
** Stock has declined ~8 pct this year
(Reporting by Amy Caren Daniel in Bengaluru)
((Reuters Messaging:
Amy.CarenDaniel.thomsonreuters.com@reuters.net))